Search research articles
Contact Us
Filters
Showing results (1-10 of 22) with videos related to
Page
of 3
Sort By:
Antimicrobial Agents and Chemotherapy
|
June 28, 2005
Compound efflux in Helicobacter pylori
Amy Kutschke, Boudewijn L M de Jonge
Antimicrobial Agents and Chemotherapy
|
September 18, 2002
The carboxyl terminus of peptidoglycan stem peptides is a determinant for methicillin resistance in Staphylococcus aureus
Boudewijn L M De Jonge, Douglas Gage, Naxing Xu
Microbiology (Reading, England)
|
October 6, 1997
The Staphylococcus aureus scdA gene: a novel locus that affects cell division and morphogenesis
Eric W Brunskill, Boudewijn L M de Jonge, Kenneth W Bayles
The Journal of Antimicrobial Chemotherapy
|
July 17, 2018
In vitro activity of ceftazidime/avibactam against isolates of Pseudomonas aeruginosa collected in European countries: INFORM global surveillance 2012-15
Krystyna M Kazmierczak, Boudewijn L M de Jonge, Gregory G Stone, et al.
The Journal of Antimicrobial Chemotherapy
|
July 17, 2018
In vitro activity of ceftazidime/avibactam against isolates of Enterobacteriaceae collected in European countries: INFORM global surveillance 2012-15
Krystyna M Kazmierczak, Boudewijn L M de Jonge, Gregory G Stone, et al.
The Journal of Antimicrobial Chemotherapy
|
February 11, 2020
Longitudinal analysis of ESBL and carbapenemase carriage among Enterobacterales and Pseudomonas aeruginosa isolates collected in Europe as part of the International Network for Optimal Resistance Monitoring (INFORM) global surveillance programme, 2013-17
Krystyna M Kazmierczak, Boudewijn L M de Jonge, Gregory G Stone, et al.
Antimicrobial Agents and Chemotherapy
|
May 25, 2016
In Vitro Susceptibility of Global Surveillance Isolates of Pseudomonas aeruginosa to Ceftazidime-Avibactam (INFORM 2012 to 2014)
Wright W Nichols, Boudewijn L M de Jonge, Krystyna M Kazmierczak, et al.
Antimicrobial Agents and Chemotherapy
|
May 11, 2021
Epidemiology of Carbapenem Resistance Determinants Identified in Meropenem-Nonsusceptible <i>Enterobacterales</i> Collected as Part of a Global Surveillance Program, 2012 to 2017
Krystyna M Kazmierczak, James A Karlowsky, Boudewijn L M de Jonge, et al.
Antimicrobial Agents and Chemotherapy
|
September 26, 2018
<i>In Vitro</i> Activity of Ceftazidime-Avibactam and Aztreonam-Avibactam against OXA-48-Carrying Enterobacteriaceae Isolated as Part of the International Network for Optimal Resistance Monitoring (INFORM) Global Surveillance Program from 2012 to 2015
Krystyna M Kazmierczak, Patricia A Bradford, Gregory G Stone, et al.
Antimicrobial Agents and Chemotherapy
|
February 4, 2015
Pyridodiazepine amines are selective therapeutic agents for helicobacter pylori by suppressing growth through inhibition of glutamate racemase but are predicted to require continuous elevated levels in plasma to achieve clinical efficacy
Boudewijn L M de Jonge, Amy Kutschke, Joseph V Newman, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 22) with videos related to
Sort By:
Page
of 3
Antimicrobial Agents and Chemotherapy
|
June 28, 2005
Compound efflux in Helicobacter pylori
Amy Kutschke, Boudewijn L M de Jonge
Antimicrobial Agents and Chemotherapy
|
September 18, 2002
The carboxyl terminus of peptidoglycan stem peptides is a determinant for methicillin resistance in Staphylococcus aureus
Boudewijn L M De Jonge, Douglas Gage, Naxing Xu
Microbiology (Reading, England)
|
October 6, 1997
The Staphylococcus aureus scdA gene: a novel locus that affects cell division and morphogenesis
Eric W Brunskill, Boudewijn L M de Jonge, Kenneth W Bayles
The Journal of Antimicrobial Chemotherapy
|
July 17, 2018
In vitro activity of ceftazidime/avibactam against isolates of Pseudomonas aeruginosa collected in European countries: INFORM global surveillance 2012-15
Krystyna M Kazmierczak, Boudewijn L M de Jonge, Gregory G Stone, et al.
The Journal of Antimicrobial Chemotherapy
|
July 17, 2018
In vitro activity of ceftazidime/avibactam against isolates of Enterobacteriaceae collected in European countries: INFORM global surveillance 2012-15
Krystyna M Kazmierczak, Boudewijn L M de Jonge, Gregory G Stone, et al.
The Journal of Antimicrobial Chemotherapy
|
February 11, 2020
Longitudinal analysis of ESBL and carbapenemase carriage among Enterobacterales and Pseudomonas aeruginosa isolates collected in Europe as part of the International Network for Optimal Resistance Monitoring (INFORM) global surveillance programme, 2013-17
Krystyna M Kazmierczak, Boudewijn L M de Jonge, Gregory G Stone, et al.
Antimicrobial Agents and Chemotherapy
|
May 25, 2016
In Vitro Susceptibility of Global Surveillance Isolates of Pseudomonas aeruginosa to Ceftazidime-Avibactam (INFORM 2012 to 2014)
Wright W Nichols, Boudewijn L M de Jonge, Krystyna M Kazmierczak, et al.
Antimicrobial Agents and Chemotherapy
|
May 11, 2021
Epidemiology of Carbapenem Resistance Determinants Identified in Meropenem-Nonsusceptible <i>Enterobacterales</i> Collected as Part of a Global Surveillance Program, 2012 to 2017
Krystyna M Kazmierczak, James A Karlowsky, Boudewijn L M de Jonge, et al.
Antimicrobial Agents and Chemotherapy
|
September 26, 2018
<i>In Vitro</i> Activity of Ceftazidime-Avibactam and Aztreonam-Avibactam against OXA-48-Carrying Enterobacteriaceae Isolated as Part of the International Network for Optimal Resistance Monitoring (INFORM) Global Surveillance Program from 2012 to 2015
Krystyna M Kazmierczak, Patricia A Bradford, Gregory G Stone, et al.
Antimicrobial Agents and Chemotherapy
|
February 4, 2015
Pyridodiazepine amines are selective therapeutic agents for helicobacter pylori by suppressing growth through inhibition of glutamate racemase but are predicted to require continuous elevated levels in plasma to achieve clinical efficacy
Boudewijn L M de Jonge, Amy Kutschke, Joseph V Newman, et al.
Page
of 3